Press "Enter" to skip to content

New patent for Astrazeneca drug SYMBICORT

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug SYMBICORT

Annual Drug Patent Expirations for SYMBICORT
Annual Drug Patent Expirations for SYMBICORT

Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug and one Paragraph IV challenge.

SYMBICORT drug price trends.

Drug patent litigation for SYMBICORT.

The generic ingredient in SYMBICORT is budesonide; formoterol fumarate dihydrate. One supplier is listed for this compound. Additional details are available on the budesonide; formoterol fumarate dihydrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug SYMBICORT
    Do NOT follow this link or you will be banned from the site!